| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 12/18/2013 | CN103459608A Recombinant polypeptide production method |
| 12/18/2013 | CN103459419A Human Lactoferrin Based Peptides Having Antiinflammatory Activity |
| 12/18/2013 | CN103458923A Method for the production of protein complexes and vaccine compositions comprising the same |
| 12/18/2013 | CN103458921A Spray dried myrosinase and use to produce isothiocyanates |
| 12/18/2013 | CN103458920A Glucagon analogs exhibiting GIP receptor activity |
| 12/18/2013 | CN103458919A Prevention of hypoglycaemia in diabetes mellitus type 2 patients |
| 12/18/2013 | CN103458918A Pegylated human HDL particle and process for production thereof |
| 12/18/2013 | CN103458917A Composition and method for treating cancer |
| 12/18/2013 | CN103458916A Long-acting peptide analogs |
| 12/18/2013 | CN103458915A Water soluble membrane proteins and methods for the preparation and use thereof |
| 12/18/2013 | CN103458914A Skin wound healing compositions and methods of use thereof |
| 12/18/2013 | CN103458913A Treatment for infection with Hepatitis B virus alone or in combination with Hepatitis Delta virus and associated liver diseases |
| 12/18/2013 | CN103458912A Method for treating disorders of the skin |
| 12/18/2013 | CN103458911A Peptide compositions and methods for treating patients |
| 12/18/2013 | CN103458910A Hot flash suppressant |
| 12/18/2013 | CN103458909A Methods and systems for treatment of migraines and other indications |
| 12/18/2013 | CN103458891A Nutritional composition |
| 12/18/2013 | CN103458879A Osmotic mediated release synthetic nanocarriers |
| 12/18/2013 | CN103458873A Fatty acid acylated amino acids for oral peptide delivery |
| 12/18/2013 | CN103451172A Modified factor vii polypeptides and uses thereof |
| 12/18/2013 | CN103450357A Thyrotropin receptor preparations, binding regions thereof, antibody and hormone interactions therewith, and uses thereof |
| 12/18/2013 | CN103450354A Huangqi glycoprotein (HQGP) and preparation method and application thereof |
| 12/18/2013 | CN103450351A Long-acting polypeptide for confronting Newcastle disease virus infection and modifier thereof |
| 12/18/2013 | CN103450349A Polyasparacyl oligopeptides with chain length of 119, and preparation method, thrombolytic effect, nano-structure and application thereof |
| 12/18/2013 | CN103450348A Mimetic peptide of erythropoietin, preparation method and applications thereof |
| 12/18/2013 | CN103450345A Vip片段和应用方法 Vip fragments and application methods |
| 12/18/2013 | CN103450344A Tetrahydroisoquinolinyl-3-carboxylic acid modified LARGD heptapeptides, and synthesis, antithrombotic activity and application thereof |
| 12/18/2013 | CN103450343A Tetrahydroisoquinolinyl-3-carboxylic acid modified TARGD heptapeptides, and synthesis, antithrombotic activity and application thereof |
| 12/18/2013 | CN103450342A Tetrahydroisoquinolinyl-3-carboxylic acid modified PARGD heptapeptides, and synthesis, antithrombotic activity and application thereof |
| 12/18/2013 | CN103450340A Heterocyclic carboxylic acid-modified anti-tumor oligopeptides and their synthesis, anti-tumor effects and application |
| 12/18/2013 | CN103450339A LRGD peptide-modified carbolino-hexahydropyrazine-1,4-diketones and their preparation method, antithrombotic effect and use |
| 12/18/2013 | CN103450338A Heterocyclic carboxylic acid-modified thymopentins and their preparation method, anti-tumor effect and use |
| 12/18/2013 | CN103450337A TRGD peptide-modified carbolino-hexahydropyrazine-1,4-diketones and their preparation method, antithrombotic effect and use |
| 12/18/2013 | CN103450335A Beta-carboline acyl tryptophyl tryptophan amino acid benzyl ester, as well as synthesis, anti-tumor action and application thereof |
| 12/18/2013 | CN103450333A 1,1-dimethyl-beta-carboline carboxylic acid-modified RGD peptides and their synthesis, anti-thrombus effect and use |
| 12/18/2013 | CN103450332A Styrene-beta-carboline-modified tripeptide benzyl ester, as well as preparation, anti-tumor activity and application thereof |
| 12/18/2013 | CN103450330A Dihydroxyltetrahydroisoquinoline-3-formyl amino acids as well as synthesis, antithrombotic effect and application thereof |
| 12/18/2013 | CN103450329A 3H-imidazo[4,5-c]pyridine-6-formyl-amido acid benzyl esters and their synthesis, anti-tumor activity and use |
| 12/18/2013 | CN103446579A Antidotes for factor xa inhibitors and methods of using the same |
| 12/18/2013 | CN103446578A New use of erythropoietin in high altitude sickness |
| 12/18/2013 | CN103446577A Medicine composition for preventing and treating arthritis and application thereof |
| 12/18/2013 | CN103446576A Modeling method of helicobacter pylori infection animal model |
| 12/18/2013 | CN103446068A Bortezomib freeze-dried composition and preparation method thereof |
| 12/18/2013 | CN103446041A Leuprorelin slow-controlled drug release stick and preparation method thereof |
| 12/18/2013 | CN103446030A External skin preparation and applications thereof |
| 12/18/2013 | CN102940877B Application of polypeptide DM29 in preparing drugs for increasing natural immunity of goats |
| 12/18/2013 | CN102940874B Application of small molecular polypeptide CW14 in preparation of goat antibacterial medicament |
| 12/18/2013 | CN102864154B Preparation method of Cathelicidins antimicrobial peptides of chicken |
| 12/18/2013 | CN102764424B Drug composition of thymopentin composed of five kinds of amino acids and preparation method thereof |
| 12/18/2013 | CN102757482B Polypeptide and application thereof |
| 12/18/2013 | CN102746380B Application of angiogenesis inhibitor polypeptide to preparation of medicine for treating tumor and rheumatoid arthritis |
| 12/18/2013 | CN102580232B Silk fibroin micro-needle system, silk fibroin nanometer particle and preparation method thereof |
| 12/18/2013 | CN102532268B Oligopeptide with breast cancer resistant activity and application thereof |
| 12/18/2013 | CN102481334B Prodrug Anti-cancer Therapy |
| 12/18/2013 | CN102286072B Staphylococcus aureus AgrC group induction system resistant auto-induced peptide (AIP) polypeptide derivatives and use thereof |
| 12/18/2013 | CN101842082B Peptide slow-release formulations |
| 12/18/2013 | CN101448527B Cell-matrix microspheres, methods for preparation and applications |
| 12/18/2013 | CN101333244B Protein purification by ion exchange chromatography |
| 12/18/2013 | CN101124240B Specific binding agents to hepatocyte growth factor |
| 12/18/2013 | CN101072577B Analogs of ShK toxin and their uses in selective inhibition of Kv1.3 potassium channels |
| 12/17/2013 | US8609823 FGF-9 variants and methods for use thereof |
| 12/17/2013 | US8609810 Methylglyoxal-scavenging compounds and their use for the prevention and treatment of pain and/or hyperalgesia |
| 12/17/2013 | US8609624 Methods and compositions for the inhibition of Stat5 in prostate cancer cells |
| 12/17/2013 | US8609621 Acid-cleavable linkers exhibiting altered rates of acid hydrolysis |
| 12/17/2013 | US8609620 Neuregulin peptides and their use |
| 12/17/2013 | US8609618 Topical palmitoyl glutathione formulations |
| 12/17/2013 | US8609617 KLF family members regulate intrinsic axon regeneration ability |
| 12/17/2013 | US8609614 GBS toxin receptor compositions and methods of use |
| 12/17/2013 | US8609613 Methods of inhibiting type 2 vascular endothelial growth factor receptors using polypeptides |
| 12/17/2013 | US8609611 Synthesis of small particles |
| 12/17/2013 | US8609610 Inhibitors of the trypsin-like site of the proteasome and methods of use thereof |
| 12/17/2013 | US8609609 Peptides and methods of use as therapeutics and screening agents |
| 12/17/2013 | US8609608 Antimicrobial peptides |
| 12/17/2013 | US8609607 Modified defensins and their use |
| 12/17/2013 | US8609606 Polypeptide acting to enhance ischemic diseases |
| 12/17/2013 | US8609605 Immunomodulatory methods for treatment of atherosclerosis via inhibition of CD4+ T cell response to APOB100 |
| 12/17/2013 | US8609604 Methods of improving the appearance of aging skin |
| 12/17/2013 | US8609395 Agonist and antagonist peptides of carcinoembryonic antigen (CEA) |
| 12/17/2013 | US8609373 Fusion protein mixture for inducing human pluripotent stem cell and preparation method there of |
| 12/17/2013 | US8609370 Highly active glycoproteins-process conditions and an efficient method for their production |
| 12/17/2013 | US8609368 Process for purifying vancomycin wet body |
| 12/17/2013 | US8609165 Dietary supplement for optimizing glucose levels, increasing energy, and improving general health |
| 12/17/2013 | US8609123 Derivatized poly(ester amide) as a biobeneficial coating |
| 12/17/2013 | US8609118 Solid oil powders |
| 12/17/2013 | US8609105 Auristatin drug linker conjugates |
| 12/17/2013 | US8609103 Megalin-based delivery of therapeutic compounds to the brain and other tissues |
| 12/17/2013 | US8609096 Monoclonal antibodies against PCBP-1 antigens, and uses therefor |
| 12/17/2013 | US8609091 Method for endocytic presentation of an immunosuppressive for the treatment of type 1 diabetes |
| 12/17/2013 | US8609090 Specific binding agents to hepatocyte growth factor |
| 12/17/2013 | US8609088 Intranasal delivery of therapeutic enzymes to the central nervous system for the treatment of lysosomal storage diseases |
| 12/17/2013 | US8609065 Molecules for targeting compounds to various selected organs, tissues or tumor cells |
| 12/17/2013 | CA2720523C Treatment of bladder dysfunction using liposomal botulinum toxin |
| 12/17/2013 | CA2674538C An insulinotropic complex using an immunoglobulin fragment |
| 12/17/2013 | CA2617578C Methods and compositions for regenerating articular cartilage |
| 12/17/2013 | CA2581680C Kallikrein inhibitors and uses thereof |
| 12/17/2013 | CA2555413C An immunoreactive 38-kda ferric binding protein of ehrlichia canis and uses thereof |
| 12/17/2013 | CA2504401C Drug delivery systems for the prevention of neointimal hyperlasia |
| 12/17/2013 | CA2501978C Pharmaceutical composition comprising octreotide microparticles |
| 12/17/2013 | CA2500577C The use of cytokine able to bind il-18bp and of inhibiting the activity of a second cytokine |
| 12/17/2013 | CA2496789C Methods for preserving organs and tissues |